What Ibract is and what it is used for?
Ibract is an anticancer medicine containing the active substance Palbociclib.
Palbociclib works by blocking proteins called cyclin-dependent kinase 4 and 6, which regulate cell growth and division. Blocking these proteins can slow down growth of cancer cells and delay the progression of your cancer.
Ibract is used to treat patients with certain types of breast cancer (hormone receptor-positive, human epidermal growth factor receptor 2-negative) which have spread beyond the original tumour and/or to other organs. It is given together with aromatase inhibitors or fulvestrant, which are used as hormonal anticancer therapies.
What you need to know before you take Ibract
Do not take Ibract:
Warnings and precautions
Talk to your doctor, pharmacist or nurse before taking Ibract.
Ibract may reduce the number of your white blood cells and weaken your immune system. Therefore, you may be at greater risk of getting an infection while you are taking Ibract.
Tell your doctor, pharmacist or nurse if you experience signs or symptoms of an infection, such as chills or fever.
You will have regular blood tests during treatment to check whether Ibract affects your blood cells (white blood cells, red blood cells, and platelets).
Ibract may cause severe or life-threatening inflammation of the lungs during treatment that can lead to death. Tell your healthcare provider right away if you have any new or worsening symptoms including:
Children and adolescents
Ibract is not to be used in children or adolescents (under 18 years of age).
Other medicines and Ibract
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. Ibract may affect the way some other medicines work.
In particular, the following may increase the risk of side effects with Ibract:
The following medicines may have increased risk of side effects when given with Ibract:
The following medicines may reduce the effectiveness of Ibract:
Ibract with food and drink
Avoid grapefruit and grapefruit juice while you are taking Ibract as it may increase the side effects of Ibract.
Pregnancy, breast-feeding and fertility
You should not use Ibract if you are pregnant.
You should avoid becoming pregnant while taking Ibract.
Discuss contraception with your doctor if there is any possibility that you or your partner may become pregnant.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Women of childbearing potential who are receiving this medicinal product, or their male partners should use adequate contraceptive methods (e.g., double-barrier contraception such as condom and diaphragm). These methods should be used during therapy and for at least 3 weeks after completing therapy for females and for males with reproductive potentials have to use contraception during the treatment and 3 months (12 weeks) after the last dose.
Breast-feeding
You should not breast-feed while taking Ibract. It is not known if Ibract is excreted in breast milk.
Fertility
Ibract may decrease fertility in men.
Therefore, men may consider sperm preservation before taking Ibract.
Driving and using machines
Tiredness is a very common side effect of Ibract. If you feel unusually tired, take special care when driving or using machines.
Ibract contains lactose and sodium
This medicine contains lactose (found in milk or dairy products). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
This medicine contains less than 1 mmol sodium (23 mg) per capsule, that is to say it is essentially ‘sodium-free’.
How to take Ibract ?
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is 125 mg of Ibract taken once a day for 3 weeks followed by 1 week without taking Ibract. Your doctor will tell you how many capsules of Ibract to take.
If you experience certain side effects while you are taking Ibract (see section 4 “Possible side effects”), your doctor may lower your dose or stop treatment, either temporarily or permanently. The dose may be lowered to one of the other available strengths 100 mg or 75mg.
Take Ibract once a day at about the same time every day with food, preferably a meal.
Swallow the capsule whole with a glass of water. Do not chew or crush the capsules. Do not open the capsules.
If you take more Ibract than you should
If you have taken too much Ibract, see a doctor or go to a hospital immediately. Urgent treatment may be necessary.
Take the box and this leaflet, so that the doctor knows what you have been taking.
If you forget to take Ibract
If you miss a dose or vomit, take your next dose as scheduled. Do not take a double dose to make up for the forgotten capsules.
If you stop taking Ibract
Do not stop taking Ibract unless your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them:
Contact your doctor immediately if you have any of these symptoms:
Other side effects with Ibract ay include:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet.
How to store Ibract
Further information
What Ibract contains
The active substance is Palbociclib.
The other ingredients are:
What Ibract looks like and contents of the pack
Ibract 75 mg capsules are hard gelatin capsules with opaque white cap and opaque white body, containing pale yellow to yellow color granular powder.
Ibract 100 mg capsules are hard gelatin capsules with opaque pink cap and opaque white body, containing pale yellow to yellow color granular powder.
Ibract 125 mg capsules are hard gelatin capsules with opaque yellow cap and opaque yellow body, containing pale yellow to yellow color granular powder.
Ibract is available in the boxes of 3 blisters, each one containing 7 capsules (21 capsules).
Manufactured by:
Actero Middle East Pharmaceutical Company, Karaj, Iran